000 01520 a2200409 4500
005 20250517191238.0
264 0 _c20180724
008 201807s 0 0 eng d
022 _a2284-0729
024 7 _a10.26355/eurrev_201711_13831
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMa, D-D
245 0 0 _aLncRNA HOTAIR contributes to the tumorigenesis of nasopharyngeal carcinoma via up-regulating FASN.
_h[electronic resource]
260 _bEuropean review for medical and pharmacological sciences
_cNov 2017
300 _a5143-5152 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aCarcinogenesis
650 0 4 _aCarcinoma
_xgenetics
650 0 4 _aCell Line, Tumor
650 0 4 _aCell Movement
650 0 4 _aCell Proliferation
650 0 4 _aCell Survival
650 0 4 _aCyclin-Dependent Kinase Inhibitor p21
_xmetabolism
650 0 4 _aFatty Acid Synthase, Type I
_xgenetics
650 0 4 _aHumans
650 0 4 _aMatrix Metalloproteinase 9
_xmetabolism
650 0 4 _aNasopharyngeal Carcinoma
650 0 4 _aNasopharyngeal Neoplasms
_xgenetics
650 0 4 _aRNA Interference
650 0 4 _aRNA, Long Noncoding
_xantagonists & inhibitors
650 0 4 _aRNA, Small Interfering
_xmetabolism
650 0 4 _aUp-Regulation
700 1 _aYuan, L-L
700 1 _aLin, L-Q
773 0 _tEuropean review for medical and pharmacological sciences
_gvol. 21
_gno. 22
_gp. 5143-5152
856 4 0 _uhttps://doi.org/10.26355/eurrev_201711_13831
_zAvailable from publisher's website
999 _c27877074
_d27877074